We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRKS icon
8351
United Parks & Resorts
PRKS
$2.11B
-615,337
Closed -$7.65M
XTIA icon
8352
XTI Aerospace
XTIA
$58.1M
0
-$12K
AIFC
8353
AI Financial Corp
AIFC
$54.2M
-2,716
Closed -$14K
TEN
8354
CALL
Tsakos Energy Navigation Ltd
TEN
$1.23B
-2,340
Closed -$53K
INEQ
8355
Columbia International Equity Income ETF
INEQ
$97.5M
-29,508
Closed -$884K
UCB
8356
United Community Banks
UCB
$4.23B
-24,096
Closed -$688K
FLG
8357
Flagstar Bank National Association
FLG
$5.92B
-9,193
Closed -$356K
TVRD
8358
PUT
Tvardi Therapeutics
TVRD
$19.1M
-364
Closed -$179K
TPC
8359
CALL
Tutor Perini Cor
TPC
$4.44B
-8,600
Closed -$244K
ENZ
8360
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
-17,900
Closed -$187K
ATSG
8361
DELISTED
Air Transport Services Group
ATSG
-172,799
Closed -$4.13M
SYRS
8362
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-6,625
Closed -$975K
SUM
8363
CALL
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-28,153
Closed -$874K
CDMO
8364
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-32,998
Closed -$104K
HTLF
8365
DELISTED
Heartland Financial USA, Inc.
HTLF
-6,635
Closed -$328K
BSCO
8366
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
-74,718
Closed -$1.57M
ROOF
8367
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
-26,532
Closed -$718K
ITI
8368
DELISTED
Iteris, Inc.
ITI
-10,616
Closed -$71K
ENSV
8369
DELISTED
Enservco Corp.
ENSV
-1,783
Closed -$14K
BIMI
8370
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
-203
Closed -$9K
ISZE
8371
DELISTED
iShares MSCI Intl Size Factor ETF
ISZE
-7,987
Closed -$217K
SDPI
8372
DELISTED
Superior Drilling Products Inc.
SDPI
-19,387
Closed -$16K
EVBG
8373
DELISTED
Everbridge, Inc. Common Stock
EVBG
-36,067
Closed -$953K
BIOL
8374
DELISTED
Biolase, Inc.
BIOL
-4
Closed -$32K
DCPH
8375
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-261,436
Closed -$4.96M

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.